drugset / Trial / NCT02489513
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120
NaSingle-groupOpen-label
Summary
The study is designed to characterize the absorption, metabolism, and excretion of AG-120 using radiolabeled drug in healthy adult male subjects to support its further development and registration.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-09
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivosidenib | Small molecule | 500 mg | Oral |
Indications
No indication recorded.